Gyre Therapeutics, Inc. (GYRE)

NASDAQ: GYRE · Real-Time Price · USD

8.28

+0.38 (4.81%)

At close: Mar 4, 2026, 4:00 PM EST

8.28

0.00 (0.00%)

After-hours: Mar 4, 2026, 4:10 PM EST

Gyre Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	107.27	105.76	113.45	102.29	7.34	41.9
Revenue Growth (YoY)	2.13%	-6.78%	10.91%	1293.98%	-82.48%	-
Cost of Revenue	4.85	3.88	4.64	4.79	7.38	9.16
Gross Profit	102.42	101.87	108.81	97.5	-0.04	32.73
Selling, General & Admin	77.79	73.62	75.82	71.61	18.96	16.18
Research & Development	12.6	12.02	13.78	16.69	68.89	52.98
Other Operating Expenses	-	0.07	86.44	-	-	-
Total Operating Expenses	90.38	85.71	176.04	88.29	87.85	69.16
Operating Income	12.03	16.16	-67.23	9.2	-87.89	-57.37
Interest Income	0.35	1.55	1.04	1.58	-	-
Other Non-Operating Income (Expense)	2.89	5.51	-10.78	-1.37	-0.04	1.13
Total Non-Operating Income (Expense)	2.89	7.06	-9.74	0.21	-0.04	1.13
Pretax Income	15.27	23.22	-76.97	9.41	-87.93	-56.24
Provision for Income Taxes	3.46	5.32	8.52	5.1	-	-
Net Income	6.65	12.09	-92.93	2.3	-87.93	-56.24
Minority Interest in Earnings	5.16	5.81	7.45	2.01	-	-
Net Income to Common	6.65	12.09	-92.93	2.3	-87.93	-56.24
Shares Outstanding (Basic)	88	85	66	64	61	1
Shares Outstanding (Diluted)	99	102	66	76	67	1
Shares Change (YoY)	3.86%	55.39%	-13.02%	13.45%	5117.44%	59.77%
EPS (Basic)	0.07	0.14	-1.41	0.04	0.26	-43.95
EPS (Diluted)	0.03	0.05	-1.41	0.03	0.24	-43.95
EPS Growth	-	-	-	-87.50%	-	-
Free Cash Flow	2.9	-5.96	17.38	5.69	-84.59	-55.32
Free Cash Flow Growth	-	-	205.25%	-	-	-
Free Cash Flow Per Share	0.03	-0.06	0.26	0.08	-1.27	-43.26
Gross Margin	95.48%	96.33%	95.91%	95.31%	-0.57%	78.13%
Operating Margin	11.22%	15.28%	-59.26%	9.00%	-1197.79%	-136.93%
Profit Margin	11.01%	16.92%	-75.35%	4.22%	-1198.32%	-134.24%
FCF Margin	2.70%	-5.63%	15.32%	5.56%	-1152.82%	-132.03%
EBITDA	13.1	17.71	-66.16	10.29	-87.6	-57.23
EBITDA Margin	12.21%	16.75%	-58.31%	10.06%	-1193.84%	-136.60%
EBIT	12.03	16.16	-67.23	9.2	-87.89	-57.37
EBIT Margin	11.22%	15.28%	-59.26%	9.00%	-1197.79%	-136.93%
Effective Tax Rate	22.65%	22.91%	-11.06%	54.16%	0.00%	0.00%

Updated Nov 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q